EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immunogenic Potential of Selected Peptides from SARS-CoV-2 Proteins and Their Ability to Block S1/ACE-2 Binding

Lara Cristina da Silva Lima iD, Thiago Demetrius Woiski iD, Juliana Ferreira de Moura iD, Roberto Rosati iD, João Carlos Minozzo iD, Emeline Huk da Silva, Aline Castro Rodrigues Lucena, Bruno Cezar Antunes, Sérgio Caldas, Myrian Morato Duarte iD, Maurício Abreu Santos, Rubens Luiz Ferreira Gusso und 7 weitere

Viruses · 2025

DOI: 10.3390/v17020165 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Lara Cristina da Silva Lima und 18 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Pesquisa Pelé Pequeno Príncipe, Curitiba 80035-000, PR, Brazil. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, Angiotensin-Converting Enzyme 2, SARS-CoV-2, Peptides. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brazilian agency Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Fundação de Amparo à Pesquisa do Estado de Minas Gerais.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The first infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease 2019 (COVID-19), occurred in December 2019. Within a single month, the disease reached other countries, spreading in a rapid and generalized manner worldwide to cause the COVID-19 pandemic. In Brazil, the number of COVID-19 cases surpassed 38 million. This study was conducted to produce antibodies against SARS-CoV-2 and investigate the immunogenic potential of synthetic peptides containing partial sequences of the main proteins (spike, membrane, and nucleocapsid proteins). In addition, we evaluated the ability of the antibodies to impair the interaction between the spike S1 protein and human ACE-2 protein, which is the main route of entry of the virus into host cells. By immunizing horses with synthetic peptides, we obtained hyperimmune sera with specific anti-SARS-CoV-2 antibodies, which were fragmented to release the F(ab’)2 portion that binds to the different SARS-CoV-2 proteins as a recombinant S1-protein and proteins from a viral lysate. The other F(ab’)2 samples also impaired the interaction between S1 protein and ACE-2 proteins, showing high potential to prevent viral spreading.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spike Glycoprotein, CoronavirusAngiotensin-Converting Enzyme 2SARS-CoV-2PeptidesAnimalsAntibodies, ViralHumansCOVID-19Protein BindingCoronavirus Nucleocapsid ProteinsHorsesAntibodies, NeutralizingBrazil

Stichwörter der Autor:innen

COVID-19F(ab’)2SARS-CoV-2antibodyimmunizationviral neutralizing

Substanzen

Spike Glycoprotein, CoronavirusAngiotensin-Converting Enzyme 2Antibodies, Viralspike protein, SARS-CoV-2ACE2 protein, humanPeptidesCoronavirus Nucleocapsid ProteinsAntibodies, Neutralizing

Autor:innen und Institutionen

  • Instituto de Pesquisa Pelé Pequeno Príncipe, Curitiba 80035-000, PR, Brazil.
  • Faculdades Pequeno Príncipe, Curitiba 80230-020, PR, Brazil.
  • Departamento de Patologia Básica, Universidade Federal do Paraná, Curitiba 81531-980, PR, Brazil.
  • Centro de Produção e Pesquisa de Imunobiológicos, Piraquara 83302-200, PR, Brazil.
  • Diretoria de Pesquisa e Desenvolvimento, Fundação Ezequiel Dias, Belo Horizonte 30510-010, MG, Brazil.

ORCID-Profile: Lara Cristina da Silva Lima, Thiago Demetrius Woiski, Juliana Ferreira de Moura, Roberto Rosati, João Carlos Minozzo, Myrian Morato Duarte, Daniele Maria Ferreira, Elizabeth Soares Fernandes, Bonald Cavalcante de Figueiredo, Lauro Mera de Souza

Förderung

  • Brazilian agency Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais

Zitieren

APA

da Silva Lima, L. C., Woiski, T. D., de Moura, J. F., Rosati, R., Minozzo, J. C., da Silva, E. H., Lucena, A. C. R., Antunes, B. C., Caldas, S., Duarte, M. M., Santos, M. A., Gusso, R. L. F., de Moura, E. L., Silva, A. P. S., Potzecki, L., Maria Ferreira, D., Fernandes, E. S., de Figueiredo, B. C., & de Souza, L. M. (2025). Immunogenic Potential of Selected Peptides from SARS-CoV-2 Proteins and Their Ability to Block S1/ACE-2 Binding. Viruses. https://doi.org/10.3390/v17020165

Vancouver

da Silva Lima LC, Woiski TD, de Moura JF, Rosati R, Minozzo JC, da Silva EH, et al. Immunogenic Potential of Selected Peptides from SARS-CoV-2 Proteins and Their Ability to Block S1/ACE-2 Binding. Viruses. 2025. doi:10.3390/v17020165

BibTeX
@article{daSilvaLima2025,
  author = {da Silva Lima, Lara Cristina and Woiski, Thiago Demetrius and de Moura, Juliana Ferreira and Rosati, Roberto and Minozzo, João Carlos and da Silva, Emeline Huk and Lucena, Aline Castro Rodrigues and Antunes, Bruno Cezar and Caldas, Sérgio and Duarte, Myrian Morato and Santos, Maurício Abreu and Gusso, Rubens Luiz Ferreira and de Moura, Erickson Luiz and Silva, Ana Paula Santos and Potzecki, Luciana and Maria Ferreira, Daniele and Fernandes, Elizabeth Soares and de Figueiredo, Bonald Cavalcante and de Souza, Lauro Mera},
  title = {Immunogenic Potential of Selected Peptides from SARS-CoV-2 Proteins and Their Ability to Block S1/ACE-2 Binding},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17020165}
}
Kostenlos starten →